Metastatic Castrate-sensitive Prostate Cancer
Oncology
Prevalence
256.0 / 100K
Incidence
111.0 / 100K/yr
4 drugs in development·4 companies·1 clinical trial
Drug Pipeline by Phase
Compare drugs
Frequently asked questions
How many drugs are in development for Metastatic Castrate-sensitive Prostate Cancer?
BioSniper tracks 4 drugs in development for Metastatic Castrate-sensitive Prostate Cancer across 4 companies.
How many clinical trials target Metastatic Castrate-sensitive Prostate Cancer?
There are 1 clinical trial targeting Metastatic Castrate-sensitive Prostate Cancer tracked by BioSniper.
What is the prevalence of Metastatic Castrate-sensitive Prostate Cancer?
The estimated prevalence of Metastatic Castrate-sensitive Prostate Cancer is approximately 256.0 per 100,000 population.
Deep-dive into Metastatic Castrate-sensitive Prostate Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis